713 related articles for article (PubMed ID: 16837437)
1. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
2. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
Apostolidis E; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
[TBL] [Abstract][Full Text] [Related]
4. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
Ademiluyi AO; Oboh G
Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
Kwon YI; Vattem DA; Shetty K
Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
8. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
Ademiluyi AO; Oboh G
J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models.
Pinto Mda S; Ranilla LG; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
J Med Food; 2009 Apr; 12(2):278-91. PubMed ID: 19459727
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of
Quan NV; Xuan TD; Tran HD; Thuy NTD; Trang LT; Huong CT; Andriana Y; Tuyen PT
Molecules; 2019 Feb; 24(3):. PubMed ID: 30744084
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe
Afolabi OB; Oloyede OI; Agunbiade SO
J Integr Med; 2018 May; 16(3):192-198. PubMed ID: 29706572
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
13. Potentially antidiabetic and antihypertensive compounds identified from Pistacia atlantica leaf extracts by LC fingerprinting.
Ahmed ZB; Yousfi M; Viaene J; Dejaegher B; Demeyer K; Mangelings D; Vander Heyden Y
J Pharm Biomed Anal; 2018 Feb; 149():547-556. PubMed ID: 29190580
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetes and antihypertension potential of commonly consumed carbohydrate sweeteners using in vitro models.
Ranilla LG; Kwon YI; Genovese MI; Lajolo FM; Shetty K
J Med Food; 2008 Jun; 11(2):337-48. PubMed ID: 18598178
[TBL] [Abstract][Full Text] [Related]
15. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
Trinh BTD; Staerk D; Jäger AK
J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
[TBL] [Abstract][Full Text] [Related]
16. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia.
Gulati V; Harding IH; Palombo EA
BMC Complement Altern Med; 2012 Jun; 12():77. PubMed ID: 22713130
[TBL] [Abstract][Full Text] [Related]
17. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
Oboh G; Ademosun AO
Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
[TBL] [Abstract][Full Text] [Related]
18. Varietal influences on antihyperglycemia properties of freshly harvested apples using in vitro assay models.
Barbosa AC; Pinto Mda S; Sarkar D; Ankolekar C; Greene D; Shetty K
J Med Food; 2010 Dec; 13(6):1313-23. PubMed ID: 20874247
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
[TBL] [Abstract][Full Text] [Related]
20. Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.
Pinto Mda S; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
Bioresour Technol; 2009 Dec; 100(24):6599-609. PubMed ID: 19665890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
